Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)

Mezzion Pharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16,993	13,617	40,246	29,399	24,210	35,854
Short-Term Investments	11,500	15,000	18,000	3,000	23,284	13,250
Cash & Short-Term Investments	28,493	28,617	58,246	32,399	47,494	49,104
Cash Growth	-17.95%	-50.87%	79.78%	-31.78%	-3.28%	19.30%
Accounts Receivable	1,104	869.93	2,309	2,644	2,368	2,565
Other Receivables	233.14	457.47	2,154	238.76	377.57	223.51
Receivables	2,167	1,757	5,925	4,203	4,435	4,248
Inventory	5,379	5,420	5,742	8,835	11,777	7,011
Prepaid Expenses	125.45	127.5	136.44	265.05	266.77	238.94
Other Current Assets	7,343	6,004	4,194	195.28	201.3	66.81
Total Current Assets	43,508	41,926	74,244	45,897	64,174	60,669
Property, Plant & Equipment	2,300	2,529	2,854	4,245	4,879	5,899
Long-Term Investments	-0	3.08	7.46	-	-0	0
Other Intangible Assets	1,620	1,620	1,620	1,620	1,620	1,620
Long-Term Deferred Charges	39,520	26,820	11,324	-	12,559	6,622
Other Long-Term Assets	647.53	821.1	1,951	1,950	672.93	656.16
Total Assets	87,884	73,998	92,149	54,022	83,935	75,625
Accounts Payable	1,896	1,646	4,030	7,173	5,503	3,466
Accrued Expenses	20,077	18,882	21,831	-	7,188	5,533
Short-Term Debt	9,293	-	499.58	1,063	932.01	985.5
Current Portion of Leases	702.54	694.38	735.87	-	1,051	1,015
Current Income Taxes Payable	-	3,892	-	-	-	803.65
Other Current Liabilities	17,425	1,556	2,519	17,844	3,823	3,711
Total Current Liabilities	49,394	26,670	29,615	26,080	18,497	15,514
Long-Term Leases	929.84	921.47	1,005	-	2,338	3,104
Pension & Post-Retirement Benefits	30.28	-	-	-	217.2	108.77
Long-Term Deferred Tax Liabilities	-	251.42	-	-	-	-
Other Long-Term Liabilities	185.3	91.98	84.61	1,702	89.78	88.78
Total Liabilities	50,539	27,935	30,705	27,782	21,141	18,816
Common Stock	15,111	14,982	14,804	13,371	4,451	4,446
Additional Paid-In Capital	167,099	159,062	150,510	99,256	107,802	107,530
Retained Earnings	-153,460	-143,148	-123,723	-111,052	-74,789	-61,166
Comprehensive Income & Other	8,594	15,167	19,854	24,665	25,330	5,999
Shareholders' Equity	37,345	46,063	61,444	26,240	62,793	56,810
Total Liabilities & Equity	87,884	73,998	92,149	54,022	83,935	75,625
Total Debt	10,926	1,616	2,241	1,063	4,321	5,104
Net Cash (Debt)	17,567	27,001	56,006	31,336	43,173	44,000
Net Cash Growth	-47.19%	-51.79%	78.73%	-27.42%	-1.88%	17.14%
Net Cash Per Share	583.82	905.33	1983.28	1172.20	1617.75	1692.10
Filing Date Shares Outstanding	30	29.96	29.61	26.74	26.7	26.68
Total Common Shares Outstanding	30	29.96	29.61	26.74	26.7	26.68
Working Capital	-5,886	15,255	44,628	19,817	45,678	45,155
Book Value Per Share	1244.99	1537.30	2075.31	981.23	2351.55	2129.45
Tangible Book Value	35,725	44,443	59,825	24,620	61,174	55,190
Tangible Book Value Per Share	1190.99	1483.24	2020.60	920.66	2290.89	2068.74
Buildings	-	-	-	23.97	23.97	7.97
Machinery	-	2,191	1,976	3,523	2,908	2,652
Construction In Progress	-	-	619.69	439.17	193.43	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.